Risk of ischaemic and haemorrhagic stroke in Chinese undergoing percutaneous coronary intervention treated with potent P2Y12 inhibitor versus clopidogrel.
Andrew Kei-Yan NgPauline Yeung NgApril IpKui Kai LauChung-Wah SiuPublished in: Stroke and vascular neurology (2022)
Potent P2Y12 inhibitors were associated with a lower adjusted risk of ischaemic stroke and thrombotic events, compared with clopidogrel. The risks of ICH and major bleeding were similar.
Keyphrases
- percutaneous coronary intervention
- atrial fibrillation
- acute coronary syndrome
- antiplatelet therapy
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery disease
- coronary artery bypass grafting
- anti inflammatory
- coronary artery bypass
- heart failure
- human health
- subarachnoid hemorrhage
- cerebral ischemia